APOE and early-onset autosomal dominant Alzheimer disease: LRP8 has long been studied for its role in cholesterol transport and metabolism; however, the identification of ApoE4, the major genetic risk factor for developing late-onset Alzheimer’s disease, as one of its ligands has brought attention to its role in CNS-related pathways and neurodegeneration (Figure 3).